Andrea D'Amico, PhD

Andrea D'Amico, PhD

Ophthalmology
Gene therapy on IRD
Liu Lab / Ocular Genomics Institute
Andrea D'Amico
Dr. Andrea D’Amico earned his Ph.D. in Biomedicine Research from Scuola Superiore Sant’Anna, Pisa, Italy. During his work, he applied his molecular biology skills to study molecular mechanisms of cardiac remodeling in tissue and blood samples of heart failure patients undergoing artificial ventricular assistance. More recently, during his first postdoctoral training, he worked in the laboratory of Dr.Richard Lee at the Harvard Department of Stem Cell and Regenerative Biology where he used CRISPR/Cas9 to create genetic engineered mouse models to study age-related cardiac hypertrophy.
Andrea joined the Ocular Genomic Institute in April 2018 as a Post-doctoral Research Fellow. He is currently utilizing the CRISPR/Cas9 genomic editing technology alongiside with molecular biologic and biochemical techniques to develop gene therapeutic strategies for the treatment of dominant IRDs.

Contact Information

Massachusetts Eye and Ear Infirmary
243 Charles St, Room 520
Boston, MA 02114

People Roles